85 related articles for article (PubMed ID: 33435133)
1.
Voutsadakis IA
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33435133
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenesis of PIK3CA.
German S; Aslam HM; Saleem S; Raees A; Anum T; Alvi AA; Haseeb A
Hered Cancer Clin Pract; 2013 Jun; 11(1):5. PubMed ID: 23768168
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations in claudin 18 suppressed and non-suppressed gastric adenocarcinomas to guide targeted therapies.
Voutsadakis IA
Tissue Barriers; 2024 May; ():2348852. PubMed ID: 38713052
[TBL] [Abstract][Full Text] [Related]
4. Analysis of genomic variation in lung adenocarcinoma patients revealed the critical role of PI3K complex.
Deng ZM; Liu L; Qiu WH; Zhang YQ; Zhong HY; Liao P; Wu YH
PeerJ; 2017; 5():e3216. PubMed ID: 28503373
[TBL] [Abstract][Full Text] [Related]
5. The landscape of driver mutations in cutaneous squamous cell carcinoma.
Chang D; Shain AH
NPJ Genom Med; 2021 Jul; 6(1):61. PubMed ID: 34272401
[TBL] [Abstract][Full Text] [Related]
6. Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data.
Duranti S; Pietragalla A; Daniele G; Nero C; Ciccarone F; Scambia G; Lorusso D
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925884
[TBL] [Abstract][Full Text] [Related]
7. Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications.
De Nola R; Loizzi V; Cicinelli E; Cormio G
Crit Rev Oncol Hematol; 2021 Jun; 162():103343. PubMed ID: 33930531
[TBL] [Abstract][Full Text] [Related]
8. Cervical Cancer Immunotherapy: Facts and Hopes.
Ferrall L; Lin KY; Roden RBS; Hung CF; Wu TC
Clin Cancer Res; 2021 Sep; 27(18):4953-4973. PubMed ID: 33888488
[TBL] [Abstract][Full Text] [Related]
9. Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update.
Verhoeven Y; Quatannens D; Trinh XB; Wouters A; Smits ELJ; Lardon F; De Waele J; van Dam PA
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670397
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma.
Huang RSP; Haberberger J; Murugesan K; Danziger N; Hiemenz M; Severson E; Duncan DL; Ramkissoon SH; Ross JS; Elvin JA; Lin DI
Mod Pathol; 2021 Jul; 34(7):1425-1433. PubMed ID: 33637877
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Systemic Therapy after Chemoradiation and Brachytherapy for Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis.
Horeweg N; Mittal P; Gradowska PL; Boere I; Chopra S; Nout RA
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919905
[TBL] [Abstract][Full Text] [Related]
12. Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives.
Krasniqi E; Barba M; Venuti A; Pizzuti L; Cappuzzo F; Landi L; Carpano S; Marchetti P; Villa A; Vizza E; Giuliano G; Mazzotta M; Marinelli D; Gnignera S; Vincenzoni C; Stranges V; Sergi D; Giordano A; Tomao F; Maugeri-Saccà M; Sanguineti G; Di Lisa FS; Tomao S; Ciliberto G; Vici P
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917435
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.
Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L
PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225
[TBL] [Abstract][Full Text] [Related]
14. Integrated Analysis of Immune Infiltration Features for Cervical Carcinoma and Their Associated Immunotherapeutic Responses.
Kang Y; Huang J; Liu Y; Zhang N; Cheng Q; Zhang Y
Front Cell Dev Biol; 2021; 9():573497. PubMed ID: 33898414
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in Cervical Cancer.
Mauricio D; Zeybek B; Tymon-Rosario J; Harold J; Santin AD
Curr Oncol Rep; 2021 Apr; 23(6):61. PubMed ID: 33852056
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer.
Chen Y; Lin H; Pi YN; Chen XX; Zhou H; Tian Y; Zhao WD; Xia BR
Front Oncol; 2021; 11():616530. PubMed ID: 33842318
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression.
Causin RL; Freitas AJA; Trovo Hidalgo Filho CM; Reis RD; Reis RM; Marques MMC
Cells; 2021 Mar; 10(3):. PubMed ID: 33803022
[TBL] [Abstract][Full Text] [Related]
18. Genomic characterisation of cervical cancer and human papillomavirus: new opportunities for precision medicine.
Franceschi S
Lancet Oncol; 2021 Apr; 22(4):419-420. PubMed ID: 33794201
[No Abstract] [Full Text] [Related]
19. Integrated analysis of virus and host transcriptomes in cervical cancer in Asian and Western populations.
Qiu Q; Zhou Q; Luo A; Li X; Li K; Li W; Yu M; Amanullah M; Lu B; Lu W; Liu P; Lu Y
Genomics; 2021 May; 113(3):1554-1564. PubMed ID: 33785400
[TBL] [Abstract][Full Text] [Related]
20. Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
Chen Q; Qiu B; Zeng X; Hu L; Huang D; Chen K; Qiu X
Cancer Cell Int; 2021 Mar; 21(1):182. PubMed ID: 33766042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
